Company
United StatesPublic company, NYSE: BIOBio-Rad Laboratories, Inc (NYSE: BIO), Woodinville, WA – FDA Inspections
Inspection records and compliance data for Bio-Rad Laboratories, Inc in Woodinville, Washington. 8 FDA inspections on record, last inspected August 08, 2018. Publicly traded as NYSE: BIO.
Company Profile
This profile covers Bio-Rad Laboratories, Inc based in Woodinville, Washington, United States.
FDA Inspection History
- FDA inspections
- 8
- OAI
- 0
- VAI
- 2
- NAI
- 6
- Form 483s
- 0
- Warning letters
- 0
First inspected November 21, 2011. Last inspected August 8, 2018.
FDA inspections (8)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| August 8, 2018 | VAI | Biologics · Blood and Blood Products | 1068747 |
| August 6, 2018 | VAI | Biologics · Blood and Blood Products | 1068742 |
| May 23, 2017 | NAI | Medical Devices & Rad Health · Compliance: Devices | 1014546 |
| May 22, 2017 | NAI | Medical Devices & Rad Health · Compliance: Devices | 1014488 |
| April 22, 2014 | NAI | Biologics · Blood and Blood Products | 876396 |
| December 2, 2013 | NAI | Medical Devices & Rad Health · Compliance: Devices | 857340 |
| January 27, 2012 | NAI | Biologics · Blood and Blood Products | 768308 |
| November 21, 2011 | NAI | Medical Devices & Rad Health · Bioresearch Monitoring | 755969 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Bio-Rad Laboratories, Inc
Stock ticker
BIO
Exchange
NYSE
Share price
$370.47
Market cap
$10.0B
Price as of
November 13, 2026
FEI Number
3008272466
Address
8415 216th St Se, Woodinville, Washington 98072, United States
Country
United States
ID: a4f5d0de-2ff0-48da-963b-f5f11f8e91b0